Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Stephen R Fussell. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Se høyest rangerte insidere
Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Stephen R Fussell har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:ABT / Abbott Laboratories Executive Vice President 113 227
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Stephen R Fussell. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Stephen R Fussell som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring		 Aksje
pris		 Transaksjons
verdi		 Gjenværende
verdi
2019-04-24 2019-04-23 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −56 000 113 227 −33,09
2019-04-24 2019-04-23 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −56 000 169 935 −24,79 76,00 −4 256 000 12 915 060
2019-04-24 2019-04-23 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 56 000 225 935 32,95 47,00 2 632 000 10 618 945
2019-03-04 2019-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 246 169 935 −1,30 78,00 −175 188 13 254 930
2019-03-04 2019-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −15 221 172 181 −8,12 77,23 −1 175 518 13 297 539
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 138 121 138 121
2019-02-26 2019-02-22 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 26 350 187 402 16,36
2018-03-02 2018-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −11 106 161 052 −6,45 60,13 −667 804 9 684 057
2018-03-02 2018-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −12 726 172 158 −6,88 60,55 −770 559 10 424 167
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −104 642 104 642 −50,00
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 233 125 −0,04 59,67 −5 967 13 910 336
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −77 233 225 −0,03 59,67 −4 594 13 916 069
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 985 233 302 −1,26 59,66 −178 100 13 919 964
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −8 206 236 287 −3,36 59,66 −489 570 14 096 882
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −10 244 493 0,00 59,66 −597 14 585 841
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 200 244 503 −1,29 59,66 −190 896 14 585 826
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −4 794 247 703 −1,90 59,65 −285 962 14 775 484
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −600 252 497 −0,24 59,64 −35 787 15 060 184
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 700 253 097 −0,67 59,64 −101 388 15 094 705
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 254 797 −0,20 59,64 −29 818 15 194 819
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 600 255 297 −0,62 59,63 −95 408 15 223 360
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −22 500 256 897 −8,05 59,60 −1 341 000 15 311 061
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 279 397 −0,04 59,60 −5 960 16 650 664
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 279 497 −0,18 59,59 −29 795 16 655 226
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 279 997 −0,18 59,58 −29 792 16 683 621
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 280 497 −0,18 59,58 −29 790 16 712 011
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −180 280 997 −0,06 59,56 −10 721 16 736 181
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −574 281 177 −0,20 59,54 −34 179 16 742 684
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −226 281 751 −0,08 59,54 −13 456 16 775 455
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −989 281 977 −0,35 59,53 −58 875 16 786 091
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −728 282 966 −0,26 59,52 −43 331 16 842 136
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 283 694 −0,07 59,52 −11 903 16 884 048
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 172 283 894 −0,41 59,51 −69 746 16 894 532
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 200 285 066 −0,42 59,50 −71 400 16 961 427
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −441 286 266 −0,15 59,50 −26 237 17 031 396
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 419 286 707 −0,49 59,49 −84 416 17 056 199
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 288 126 −0,10 59,48 −17 844 17 137 734
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 100 288 426 −0,38 59,47 −65 417 17 152 694
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 104 642 289 526 56,60 38,40 4 018 253 11 117 798
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 246 963 246 963
2018-02-21 2018-02-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 44 909 184 884 32,08
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −900 184 884 −0,48 59,86 −53 874 11 067 156
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 185 784 −0,05 59,86 −5 986 11 120 566
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −400 185 884 −0,21 59,86 −23 942 11 126 087
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 000 186 284 −0,53 59,85 −59 850 11 149 097
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 100 187 284 −0,58 59,84 −65 824 11 207 075
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 832 188 384 −0,96 59,83 −109 609 11 271 015
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 190 216 −0,11 59,82 −11 964 11 378 721
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 200 190 416 −0,63 59,82 −71 778 11 389 733
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 191 616 −0,05 59,81 −5 981 11 460 553
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 191 716 −0,05 59,81 −5 981 11 466 055
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 500 191 816 −0,78 59,80 −89 700 11 470 597
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 193 316 −0,10 59,80 −11 959 11 559 330
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −600 193 516 −0,31 59,79 −35 874 11 570 322
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −304 194 116 −0,16 59,78 −18 175 11 605 225
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −900 194 420 −0,46 59,78 −53 802 11 622 428
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 300 195 320 −0,66 59,78 −77 708 11 675 253
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 500 196 620 −1,26 59,77 −149 425 11 751 977
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −740 199 120 −0,37 59,76 −44 226 11 900 407
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 419 199 860 −1,68 59,76 −204 319 11 943 634
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 700 203 279 −0,83 59,76 −101 584 12 146 937
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 100 204 979 −1,49 59,75 −185 225 12 247 495
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −106 208 079 −0,05 59,74 −6 333 12 431 680
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −600 208 185 −0,29 59,74 −35 844 12 436 972
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −116 208 785 −0,06 59,74 −6 929 12 471 772
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 600 208 901 −0,76 59,73 −95 568 12 477 657
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 210 501 −0,05 59,73 −5 973 12 572 698
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −628 210 601 −0,30 59,72 −37 507 12 578 145
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 294 211 229 −0,61 59,72 −77 278 12 614 596
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 900 212 523 −1,35 59,71 −173 159 12 689 748
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 215 423 −0,09 59,70 −11 941 12 861 830
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 900 215 623 −0,87 59,70 −113 430 12 872 693
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −901 217 523 −0,41 59,70 −53 785 12 985 035
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 300 218 424 −1,04 59,69 −137 287 13 037 729
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 999 220 724 −1,34 59,68 −178 995 13 173 912
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 774 223 723 −1,22 59,68 −165 552 13 351 789
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −600 226 497 −0,26 59,68 −35 805 13 516 208
2018-02-21 2018-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −6 028 227 097 −2,59 59,67 −359 691 13 550 878
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 139 975 −0,14 62,89 −12 578 8 803 028
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −600 140 175 −0,43 62,87 −37 722 8 812 802
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −700 140 775 −0,49 62,86 −44 002 8 849 116
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −600 141 475 −0,42 62,86 −37 713 8 892 411
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 400 142 075 −0,98 62,85 −87 990 8 929 414
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 198 143 475 −0,83 62,84 −75 288 9 016 686
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 502 144 673 −2,36 62,84 −220 066 9 091 251
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −662 148 175 −0,44 62,84 −41 597 9 310 576
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 506 148 837 −2,30 62,83 −220 282 9 351 429
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −945 152 343 −0,62 62,82 −59 370 9 570 949
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 500 153 288 −2,23 62,82 −219 870 9 629 552
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 394 156 788 −1,50 62,82 −150 379 9 848 638
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 008 159 182 −1,85 62,81 −188 932 9 998 221
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −799 162 190 −0,49 62,80 −50 181 10 186 343
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −900 162 989 −0,55 62,80 −56 520 10 235 709
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 163 889 −0,12 62,80 −12 559 10 291 410
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −331 164 089 −0,20 62,79 −20 783 10 303 148
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −700 164 420 −0,42 62,78 −43 946 10 322 288
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −499 165 120 −0,30 62,78 −31 325 10 365 408
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 103 165 619 −1,25 62,77 −132 005 10 395 905
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 270 167 722 −0,75 62,76 −79 712 10 527 071
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 400 168 992 −1,40 62,76 −150 624 10 605 938
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 231 171 392 −0,71 62,76 −77 251 10 755 705
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 300 172 623 −1,31 62,75 −144 325 10 832 093
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −497 174 923 −0,28 62,74 −31 184 10 975 544
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 690 175 420 −2,06 62,74 −231 511 11 005 851
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −303 179 110 −0,17 62,74 −19 009 11 236 466
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −307 179 413 −0,17 62,73 −19 258 11 254 577
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 179 720 −0,06 62,72 −6 272 11 272 937
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −400 179 820 −0,22 62,72 −25 088 11 278 310
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −103 180 220 −0,06 62,72 −6 460 11 302 497
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 180 323 −0,11 62,70 −12 541 11 307 154
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −103 180 523 −0,06 62,70 −6 458 11 318 792
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −400 180 626 −0,22 62,69 −25 076 11 323 444
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 181 026 −0,17 62,68 −18 804 11 346 710
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 181 326 −0,17 62,66 −18 798 11 361 887
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 181 626 −0,16 62,65 −18 795 11 378 869
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 181 926 −0,05 62,64 −6 264 11 395 845
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −112 182 026 −0,06 62,62 −7 013 11 398 468
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 182 138 −0,11 62,95 −12 590 11 465 587
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 000 182 338 −0,55 62,94 −62 940 11 476 354
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 100 183 338 −1,13 62,93 −132 153 11 537 460
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −7 577 185 438 −3,93 62,92 −476 745 11 667 759
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −745 193 015 −0,38 62,91 −46 868 12 142 574
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −755 193 760 −0,39 62,90 −47 490 12 187 504
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 200 194 515 −1,12 62,89 −138 358 12 233 048
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 196 715 −0,25 62,88 −31 442 12 370 423
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 702 197 215 −0,86 62,88 −107 022 12 400 879
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −504 198 917 −0,25 62,88 −31 689 12 506 906
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 790 199 421 −1,38 62,87 −175 407 12 537 598
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −102 202 211 −0,05 62,86 −6 412 12 711 995
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −800 202 313 −0,39 62,86 −50 288 12 717 395
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −17 200 203 113 −7,81 62,86 −1 081 106 12 766 668
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 400 220 313 −1,08 62,85 −150 840 13 846 672
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 851 222 713 −0,82 62,84 −116 326 13 996 398
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 502 224 564 −1,54 62,84 −220 066 14 111 602
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 404 228 066 −1,04 62,84 −151 055 14 330 527
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −20 796 230 470 −8,28 62,83 −1 306 613 14 480 430
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 702 251 266 −0,67 62,82 −106 928 15 785 786
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −6 398 252 968 −2,47 62,82 −401 922 15 891 450
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −700 259 366 −0,27 62,82 −43 972 16 292 724
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −41 413 260 066 −13,74 62,82 −2 601 358 16 336 046
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 297 301 479 −0,76 62,81 −144 275 18 935 896
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −18 700 303 776 −5,80 62,80 −1 174 454 19 078 652
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 683 322 476 −1,13 62,80 −231 292 20 251 493
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 326 159 −0,09 62,80 −18 839 20 481 970
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −12 125 326 459 −3,58 62,80 −761 389 20 499 993
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −4 225 338 584 −1,23 62,79 −265 288 21 259 689
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −400 342 809 −0,12 62,79 −25 115 21 524 120
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 343 209 −0,15 62,78 −31 392 21 548 377
2018-02-01 2018-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 000 561 518 −0,18 62,68 −62 680 35 195 948
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −104 642 209 284 −33,33
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −134 741 0 −100,00
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −149 600 0 −100,00
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −32 143 343 709 −8,55 62,78 −2 017 938 21 578 051
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −800 375 852 −0,21 62,78 −50 222 23 595 049
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 328 376 652 −0,35 62,78 −83 365 23 644 329
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −6 986 377 980 −1,81 62,77 −438 511 23 725 805
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −800 384 966 −0,21 62,77 −50 214 24 163 353
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −4 886 385 766 −1,25 62,76 −306 670 24 212 603
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 703 390 652 −0,94 62,76 −232 400 24 517 320
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −4 724 394 355 −1,18 62,76 −296 455 24 747 748
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −53 383 399 079 −11,80 62,75 −3 349 783 25 042 207
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 615 452 462 −0,57 62,75 −164 085 28 390 859
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −83 546 455 077 −15,51 62,74 −5 242 094 28 553 806
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −8 400 538 623 −1,54 62,74 −527 016 33 793 207
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −4 017 547 023 −0,73 62,74 −252 006 34 317 488
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −5 903 551 040 −1,06 62,73 −370 295 34 566 739
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 010 556 943 −0,54 62,72 −188 802 34 934 250
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −9 559 953 0,00 62,72 −564 35 117 452
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 559 962 −0,02 62,71 −6 271 35 115 217
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 560 062 −0,09 62,70 −31 352 35 118 688
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −356 560 562 −0,06 62,70 −22 321 35 147 237
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 560 918 −0,05 62,70 −18 808 35 166 754
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 561 218 −0,05 62,68 −18 806 35 179 950
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 562 518 −0,02 62,68 −6 268 35 255 816
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 562 618 −0,05 62,66 −18 800 35 256 457
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −3 303 562 918 −0,58 62,66 −206 966 35 272 442
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 566 221 −0,09 62,66 −31 328 35 476 577
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −4 400 566 721 −0,77 62,65 −275 660 35 505 071
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 104 642 571 121 22,43 38,40 4 018 253 21 931 046
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 134 741 466 479 40,62 39,12 5 271 068 18 248 658
2018-02-01 2018-01-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 149 600 331 738 82,14 34,94 5 227 024 11 590 926
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −44 000 0 −100,00
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −45 800 0 −100,00
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −28 700 0 −100,00
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −38 700 0 −100,00
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −39 350 0 −100,00
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −196 550 182 138 −51,90 49,50 −9 729 225 9 015 831
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 44 000 378 688 13,15 27,03 1 189 478 10 237 300
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 45 800 334 688 15,85 22,39 1 025 549 7 494 300
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 28 700 288 888 11,03 26,19 751 593 7 565 370
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 38 700 260 188 17,47 26,02 1 006 780 6 768 791
2017-08-18 2017-08-16 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 39 350 221 488 21,60 26,70 1 050 539 5 913 132
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −44 000 0 −100,00
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −45 800 0 −100,00
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −28 700 0 −100,00
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −38 700 0 −100,00
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −39 350 0 −100,00
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −195 700 182 138 −51,79 46,00 −9 002 200 8 378 348
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 377 838 −0,08 46,01 −13 803 17 384 326
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −500 378 138 −0,13 46,02 −23 010 17 401 911
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −50 378 638 −0,01 46,93 −2 347 17 769 860
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 44 000 378 688 13,15 27,03 1 189 478 10 237 300
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 45 800 334 688 15,85 22,39 1 025 549 7 494 300
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 28 700 288 888 11,03 26,19 751 593 7 565 370
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 38 700 260 188 17,47 26,02 1 006 780 6 768 791
2017-06-09 2017-06-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 39 350 221 488 21,60 26,70 1 050 539 5 913 132
2017-03-02 2017-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −11 380 182 138 −5,88 45,46 −517 335 8 279 993
2017-02-22 2017-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 182 242 182 242
2017-02-22 2017-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 26 351 193 518 15,76
2017-02-02 2017-01-31 4 ABT ABBOTT LABORATORIES
Common shares without par value 		P - Purchase 12 200 167 167 7,87 40,77 497 394 6 815 399
2016-07-29 2016-07-28 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −41 500 0 −100,00
2016-07-29 2016-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −7 000 154 967 −4,32 45,02 −315 140 6 976 614
2016-07-29 2016-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −34 500 161 967 −17,56 45,00 −1 552 500 7 288 515
2016-07-29 2016-07-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 41 500 196 467 26,78 25,25 1 047 713 4 960 026
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 340 154 967 −0,86 39,26 −52 610 6 084 159
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −62 156 307 −0,04 39,26 −2 434 6 137 394
2016-03-02 2016-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −10 039 156 369 −6,03 39,52 −396 741 6 179 703
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 313 926 313 926
2016-02-23 2016-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 35 807 166 408 27,42
2015-08-20 2015-08-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 130 601 −0,23 50,48 −15 142 6 592 085
2015-08-20 2015-08-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 300 130 901 −0,98 50,47 −65 614 6 606 835
2015-08-20 2015-08-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 000 132 201 −0,75 50,47 −50 470 6 672 184
2015-08-20 2015-08-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −100 133 201 −0,08 50,46 −5 046 6 721 589
2015-08-20 2015-08-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −10 396 133 301 −7,23 50,46 −524 582 6 726 368
2015-08-13 2015-08-11 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −41 500 0 −100,00
2015-08-13 2015-08-11 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −28 404 143 697 −16,50 50,66 −1 438 947 7 279 690
2015-08-13 2015-08-11 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 41 500 172 101 31,78 21,22 880 605 3 651 880
2015-03-03 2015-02-27 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −11 459 130 601 −8,07 47,61 −545 563 6 217 914
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 169 227 169 227
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 24 015 142 060 20,34
2014-09-19 2014-09-18 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −17 400 0 −100,00
2014-09-19 2014-09-18 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −14 500 0 −100,00
2014-09-19 2014-09-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −23 619 118 045 −16,67 43,38 −1 024 592 5 120 792
2014-09-19 2014-09-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 17 400 141 664 14,00 23,22 404 000 3 289 211
2014-09-19 2014-09-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 14 500 124 264 13,21 22,27 322 872 2 766 986
2014-03-04 2014-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −13 414 109 764 −10,89 39,79 −533 743 4 367 510
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 134 741 134 741
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Common Shares without par value 		A - Award 22 009 123 178 21,75
2013-11-08 2013-11-08 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −1 227 0 −100,00
2013-11-08 2013-11-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −642 101 169 −0,63 37,64 −24 165 3 808 001
2013-11-08 2013-11-08 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 1 227 101 811 1,22 19,72 24 192 2 007 336
2013-11-08 2013-11-07 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −7 558 0 −100,00
2013-11-08 2013-11-07 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −2 908 0 −100,00
2013-11-08 2013-11-07 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −10 466 100 584 −9,42 37,59 −393 417 3 780 953
2013-11-08 2013-11-07 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 7 558 111 050 7,30 25,17 190 266 2 795 584
2013-11-08 2013-11-07 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 2 908 103 492 2,89 25,52 74 226 2 641 613
2013-03-01 2013-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −11 974 100 584 −10,64 34,26 −410 229 3 446 008
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −666 112 558 −0,59 34,80 −23 177 3 917 131
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 400 113 224 −2,08 34,80 −83 525 3 940 422
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −8 269 115 624 −6,67 35,08 −290 077 4 056 090
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 149 600 149 600
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 28 800 123 893 30,29
2013-02-04 2013-02-01 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −9 690 0 −100,00
2013-02-04 2013-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −9 690 95 093 −9,25 33,89 −328 394 3 222 702
2013-02-04 2013-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 9 690 104 783 10,19 31,90 309 123 3 342 703
2012-10-26 2012-10-24 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −5 948 0 −100,00
2012-10-26 2012-10-24 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 000 95 093 −2,06 66,00 −132 000 6 276 138
2012-10-26 2012-10-24 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −5 948 97 093 −5,77 66,00 −392 568 6 408 138
2012-10-26 2012-10-24 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 5 948 103 041 6,13 60,39 359 200 6 222 646
2012-08-01 2012-07-30 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 9 690 9 690
2012-08-01 2012-07-30 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −10 988 0 −100,00
2012-08-01 2012-07-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −9 690 97 093 −9,07 66,39 −643 319 6 446 004
2012-08-01 2012-07-30 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 10 988 106 783 11,47 53,00 582 364 5 659 499
2012-07-03 2012-06-29 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −2 275 0 −100,00
2012-07-03 2012-06-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −2 275 95 795 −2,32 64,42 −146 558 6 171 210
2012-07-03 2012-06-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 2 275 98 070 2,37 50,95 115 911 4 996 666
2012-06-04 2012-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −4 100 95 795 −4,10 61,21 −250 961 5 863 612
2012-06-04 2012-06-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −1 900 99 895 −1,87 61,21 −116 301 6 114 673
2012-03-23 2012-03-22 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 5 948 5 948
2012-03-23 2012-03-22 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −5 818 0 −100,00
2012-03-23 2012-03-22 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −1 525 0 −100,00
2012-03-23 2012-03-22 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −5 948 101 795 −5,52 60,39 −359 200 6 147 400
2012-03-23 2012-03-22 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 5 818 107 743 5,71 47,82 278 217 5 152 270
2012-03-23 2012-03-22 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 1 525 101 925 1,52 33,23 50 678 3 387 110
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 100 400 −0,20 56,70 −11 341 5 693 182
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −200 100 600 −0,20 56,70 −11 340 5 704 070
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −467 100 800 −0,46 56,70 −26 479 5 715 461
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −40 101 267 −0,04 56,70 −2 268 5 742 041
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes −10 259 101 307 −9,20 57,04 −585 173 5 778 551
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 44 000 44 000
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 24 400 111 566 27,99
2012-02-03 2012-02-01 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise −21 281 0 −100,00
2012-02-03 2012-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −800 87 166 −0,91 54,24 −43 393 4 727 945
2012-02-03 2012-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −800 87 966 −0,90 54,24 −43 392 4 771 293
2012-02-03 2012-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −300 88 766 −0,34 54,24 −16 272 4 814 677
2012-02-03 2012-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale −19 381 89 066 −17,87 54,24 −1 051 225 4 830 940
2012-02-03 2012-02-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 21 281 108 447 24,41 53,62 1 141 194 5 815 470
2005-06-03 3 ABT ABBOTT LABORATORIES
Common shares without par value 		31 972
2005-06-03 3 ABT ABBOTT LABORATORIES
Common shares without par value 		1 084
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)